COVID – 19 | Vaccination Update – Day 557

ad
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 202.77 Crore (2,02,77,29,103today. More than 25 lakh (25,11,370Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10411291
2nd Dose 10087579
Precaution Dose 6217811
FLWs 1st Dose 18429762
2nd Dose 17666649
Precaution Dose 11956637
Age Group 12-14 years 1st Dose 38666685
  2nd Dose 27309889
Age Group 15-18 years 1st Dose 61065442
  2nd Dose 50718067
Age Group 18-44 years 1st Dose 559344665
2nd Dose 507992097
Precaution Dose 16824313
Age Group 45-59 years 1st Dose 203654756
2nd Dose 195098435
Precaution Dose 11871171
Over 60 years 1st Dose 127420221
2nd Dose 121917230
Precaution Dose 31076403
Cumulative 1st dose administered 1018992822
Cumulative 2nd dose administered 930789946
Precaution Dose 77946335
Total 2027729103

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 26th July, 2022 (557th Day)
HCWs 1st Dose 68
2nd Dose 606
Precaution Dose 17527
FLWs 1st Dose 165
2nd Dose 1113
Precaution Dose 45775
Age Group 12-14 years 1st Dose 64186
  2nd Dose 90966
Age Group 15-18 years 1st Dose 20532
  2nd Dose 42324
Age Group 18-44 years 1st Dose 34146
2nd Dose 148895
Precaution Dose 1049804
Age Group 45-59 years 1st Dose 5375
2nd Dose 34864
Precaution Dose 674605
Over 60 years 1st Dose 3732
2nd Dose 21616
Precaution Dose 255071
Cumulative 1st dose administered 128204
Cumulative 2nd dose administered 340384
Precaution Dose 2042782
Total 2511370

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply